1Harris, WS, Mozaffarian, D, Rimm, E, et al. (2009) Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 119, 902–907.
2Mozaffarian, D, Micha, R & Wallace, S (2010) Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 7, e1000252.
3Blasbalg, TL, Hibbeln, JR, Ramsden, CE, et al. (2011) Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr 93, 950–962.
4Lands, WE, Libelt, B, Morris, A, et al. (1992) Maintenance of lower proportions of (n-6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n-3) fatty acids. Biochim Biophys Acta 1180, 147–162.
5Artmann, A, Petersen, G, Hellgren, LI, et al. (2008) Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim Biophys Acta 1781, 200–212.
6Wood, JT, Williams, JS, Pandarinathan, L, et al. (2010) Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma. J Lipid Res 51, 1416–1423.
7Matias, I, Petrosino, S, Racioppi, A, et al. (2008) Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: effect of high fat diets. Mol Cell Endocrinol 286, S66–S78.
8Osei-Hyiaman, D, DePetrillo, M, Pacher, P, et al. (2005) Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 115, 1298–1305.
9Starowicz, KM, Cristino, L, Matias, I, et al. (2008) Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. Obesity 16, 553–565.
10Alvheim, AR, Malde, MK, Osei-Hyiaman, D, et al. (2012) Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity. Obesity (Silver Spring) .
11Berger, A, Crozier, G, Bisogno, T, et al. (2001) Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proc Natl Acad Sci U S A 98, 6402–6406.
12Di Marzo, V, Griinari, M, Carta, G, et al. (2010) Dietary krill oil increases docosahexaenoic acid and reduces 2-arachidonoylglycerol but not N-acylethanolamine levels in the brain of obese Zucker rats. Int Dairy J 20, 231–235.
13Piscitelli, F, Carta, G, Bisogno, T, et al. (2011) Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice. Nutr Metab 8, 51–67.
14Watanabe, S, Doshi, M & Hamazaki, T (2003) n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice. Prostaglandins Leukot Essent Fatty Acids 69, 51–59.
15Batetta, B, Griinari, M, Carta, G, et al. (2009) Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. J Nutr 139, 1495–1501.
16Cota, D, Marsicano, G, Tschop, M, et al. (2003) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112, 423–431.
17Ailhaud, G, Guesnet, P & Cunnane, SC (2008) An emerging risk factor for obesity: does disequilibrium of polyunsaturated fatty acid metabolism contribute to excessive adipose tissue development? Br J Nutr 100, 461–470.
18Madsen, L, Pedersen, LM, Liaset, B, et al. (2008) cAMP-dependent signaling regulates the adipogenic effect of n-6 polyunsaturated fatty acids. J Biol Chem 283, 7196–7205.
19Massiera, F, Saint-Marc, P, Seydoux, J, et al. (2003) Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern? J Lipid Res 44, 271–279.
20Matias, I, Carta, G, Murru, E, et al. (2008) Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes. Biochim Biophys Acta 1781, 52–60.
21Dayton, S, Hashimoto, S, Dixon, W, et al. (1966) Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. J Lipid Res 7, 103–111.
22Cunnane, SC, Manku, MS & Horrobin, DF (1985) Essential fatty acids in the liver and adipose tissue of genetically obese mice: effect of supplemental linoleic and gamma-linolenic acids. Br J Nutr 53, 441–448.
23Ikemoto, S, Takahashi, M, Tsunoda, N, et al. (1996) High-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils. Metabolism 45, 1539–1546.
24Massiera, F, Barbry, P, Guesnet, P, et al. (2010) A Western-like fat diet is sufficient to induce a gradual enhancement in fat mass over generations. J Lipid Res 51, 2352–2361.
25Okuno, M, Kajiwara, K, Imai, S, et al. (1997) Perilla oil prevents the excessive growth of visceral adipose tissue in rats by down-regulating adipocyte differentiation. J Nutr 127, 1752–1757.
26Belzung, F, Raclot, T & Groscolas, R (1993) Fish oil n-3 fatty acids selectively limit the hypertrophy of abdominal fat depots in growing rats fed high-fat diets. Am J Physiol 264, R1111–R1118.
27Hill, JO, Peters, JC, Lin, D, et al. (1993) Lipid accumulation and body fat distribution is influenced by type of dietary fat fed to rats. Int J Obes Relat Metab Disord 17, 223–236.
28Kunesova, M, Braunerova, R, Hlavaty, P, et al. (2006) The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiol Res 55, 63–72.
29Mori, T, Kondo, H, Hase, T, et al. (2007) Dietary fish oil upregulates intestinal lipid metabolism and reduces body weight gain in C57BL/6J mice. J Nutr 137, 2629–2634.
30Thorsdottir, I, Tomasson, H, Gunnarsdottir, I, et al. (2007) Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content. Int J Obes (Lond) 31, 1560–1566.
31Despres, JP (2007) The endocannabinoid system: a new target for the regulation of energy balance and metabolism. Crit Pathw Cardiol 6, 46–50.
32Van Gaal, LF, Rissanen, AM, Scheen, AJ, et al. (2005) Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 365, 1389–1397.
33Christensen, R, Kristensen, PK, Bartels, EM, et al. (2007) Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 370, 1706–1713.
34Christopoulou, FD & Kiortsis, DN (2011) An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity. J Clin Pharm Ther 36, 10–18.
35Elphick, MR & Egertova, M (2001) The neurobiology and evolution of cannabinoid signalling. Philos Trans R Soc Lond B Biol Sci 356, 381–408.
36De Petrocellis, L, Melck, D, Bisogno, T, et al. (1999) Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response. Neuroscience 92, 377–387.
37Soderstrom, K, Tian, Q, Valenti, M, et al. (2004) Endocannabinoids link feeding state and auditory perception-related gene expression. J Neurosci 24, 10013–10021.
38Valenti, M, Cottone, E, Martinez, R, et al. (2005) The endocannabinoid system in the brain of Carassius auratus and its possible role in the control of food intake. J Neurochem 95, 662–672.
39Yamaguchi, F, Macrae, AD & Brenner, S (1996) Molecular cloning of two cannabinoid type 1-like receptor genes from the puffer fish Fugu rubripes. Genomics 35, 603–605.
40Sepe, N, De Petrocellis, L, Montanaro, F, et al. (1998) Bioactive long chain N-acylethanolamines in five species of edible bivalve molluscs. Possible implications for mollusc physiology and sea food industry. Biochim Biophys Acta 1389, 101–111.
41Kirkham, TC, Williams, CM, Fezza, F, et al. (2002) Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136, 550–557.
42Piccinetti, CC, Migliarini, B, Petrosino, S, et al. (2010) Anandamide and AM251, via water, modulate food intake at central and peripheral level in fish. Gen Comp Endocrinol 166, 259–267.
43Tacon, AGJ, Hasan, MR & Subasinghe, RP (2006) Use of fishery resources as feed inputs for aquaculture development: trends and policy implications. In FAO Fish Circ no. 1018, p. 99Rome: FAO.
44Torstensen, BE, Bell, JG, Rosenlund, G, et al. (2005) Tailoring of Atlantic salmon (Salmo salar L.) flesh lipid composition and sensory quality by replacing fish oil with a vegetable oil blend. J Agric Food Chem 53, 10166–10178.
45Turchini, GM, Torstensen, BT & Ng, WK (2009) Fish oil replacement in finfish nutrition. Rev Aquacult 1, 10–57.
46Grisdale-Helland, B, Ruyter, B, Rosenlund, G, et al. (2002) Influence of high contents of dietary soybean oil on growth, feed utilization, tissue fatty acid composition, heart histology and standard oxygen consumption of Atlantic salmon (Salmo salar) raised at two temperatures. Aquaculture 207, 311–329.
47Lie, O & Lambertsen, G (1991) Fatty-acid composition of glycerophospholipids in seven tissues of cod (Gadus morhua), determined by combined high-performance liquid-chromatography and gas-chromatography. J Chromatogr 565, 119–129.
48Torstensen, BE, Nanton, DA, Olsvik, PA, et al. (2009) Gene expression of fatty acid-binding proteins, fatty acid transport proteins (cd36 and FATP) and beta-oxidation-related genes in Atlantic salmon (Salmo salar L.) fed fish oil or vegetable oil. Aquacult Nutr 15, 440–451.
49Jordal, A-EO, Lie, Ø & Torstensen, BE (2007) Complete replacement of dietary fish oil with a vegetable oil blend affect liver lipid and plasma lipoprotein levels in Atlantic salmon (Salmo salar L.). Aqua Nutr 13, 114–130.
50Bell, JG, Dick, JR, Mc Vicar, AH, et al. (1993) Dietary sunflower, linseed and fish oils affect phospholipid fatty acid composition, development of cardiac lesions, phospholipase activity and eicosanoid production in Atlantic salmon. Prostaglandins Leukot Essent Fatty Acids 49, 665–673.
51Ailhaud, G, Massiera, F, Weill, P, et al. (2006) Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. Prog Lipid Res 45, 203–236.
52Javadi, M, Everts, H, Hovenier, R, et al. (2004) The effect of six different C18 fatty acids on body fat and energy metabolism in mice. Br J Nutr 92, 391–399.
53Pellizzon, M, Buison, A, Ordiz, F, et al. (2002) Effects of dietary fatty acids and exercise on body-weight regulation and metabolism in rats. Obes Res 10, 947–955.
54Takahashi, Y & Ide, T (2000) Dietary n-3 fatty acids affect mRNA level of brown adipose tissue uncoupling protein 1, and white adipose tissue leptin and glucose transporter 4 in the rat. Br J Nutr 84, 175–184.
55Banni, S, Carta, G, Murru, E, et al. (2011) Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects. Nutr Metab (Lond) 8, 7–13.
56Huber, J, Loffler, M, Bilban, M, et al. (2007) Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids. Int J Obes (Lond) 31, 1004–1013.
57Perez-Echarri, N, Perez-Matute, P, Marcos-Gomez, B, et al. (2008) Differential inflammatory status in rats susceptible or resistant to diet-induced obesity: effects of EPA ethyl ester treatment. Eur J Nutr 47, 380–386.
58Todoric, J, Loffler, M, Huber, J, et al. (2006) Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids. Diabetologia 49, 2109–2119.
59Oh, DY, Talukdar, S, Bae, EJ, et al. (2010) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687–698.
60Bannenberg, GL, Chiang, N, Ariel, A, et al. (2005) Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol 174, 4345–4355.
61Ma, T, Liaset, B, Hao, Q, et al. (2011) Sucrose counteracts the anti-inflammatory effect of fish oil in adipose tissue and increases obesity development in mice. PLoS One 6, e21647.
62Ruyter, B, Moya-Falcon, C, Rosenlund, G, et al. (2006) Fat content and morphology of liver and intestine of Atlantic salmon (Salmo salar): effects of temperature and dietary soybean oil. Aquaculture 252, 441–452.
63Torstensen, BE, Espe, M, Stubhaug, I, et al. (2011) Dietary plant proteins and vegetable oil blends increase adiposity and plasma lipids in Atlantic salmon (Salmo salar L.). Br J Nutr 3, 1–15.
64Torstensen, BE, Jordal, AEO & Lie, O (2007) Complete replacement of dietary fish oil with a vegetable oil blend affect liver lipid and plasma lipoprotein levels in Atlantic salmon (Salmo salar L.). Aquacult Nutr 13, 114–130.
65Morais, S, Pratoomyot, J, Torstensen, BE, et al. (2011) Diet × genotype interactions in hepatic cholesterol and lipoprotein metabolism in Atlantic salmon (Salmo salar) in response to replacement of dietary fish oil with vegetable oil. Br J Nutr 106, 1457–1469.
66Morais, S, Pratoomyot, J, Taggart, JB, et al. (2011) Genotype-specific responses in Atlantic salmon (Salmo salar) subject to dietary fish oil replacement by vegetable oil: a liver transcriptomic analysis. BMC Genomics 12, 255–272.
67Torstensen, BE, Espe, M, Sanden, M, et al. (2008) Novel production of Atlantic salmon (Salmo salar) protein based on combined replacement of fish meal and fish oil with plant meal and vegetable oil blends. Aquaculture 285, 193–200.
69Harris, WS & von Schacky, C (2004) The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 39, 212–220.
70Lands, B (2009) Measuring blood fatty acids as a surrogate indicator for coronary heart disease risk in population studies. World Rev Nutr Diet 100, 22–34.